Lead optimization of novel quinolone chalcone compounds by a structure–activity relationship (SAR) study to increase efficacy and metabolic stability
Abstract Many agents targeting the colchicine binding site in tubulin have been developed as potential anticancer agents. However, none has successfully made it to the clinic, due mainly to dose limiting toxicities and the emergence of multi-drug resistance. Chalcones targeting tubulin have been pro...
Guardado en:
Autores principales: | James Knockleby, Aïcha Dede Djigo, Indeewari Kalhari Lindamulage, Chandrabose Karthikeyan, Piyush Trivedi, Hoyun Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/694e10661bf04f269dc3923c74b6cb41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Production of the antimicrobial compound tetrabromopyrrole and the Pseudomonas quinolone system precursor, 2-heptyl-4-quinolone, by a novel marine species Pseudoalteromonas galatheae sp. nov.
por: Sara Skøtt Paulsen, et al.
Publicado: (2020) -
Quinolones. A new generation
Publicado: (2000) -
A conserved strategy of chalcone isomerase-like protein to rectify promiscuous chalcone synthase specificity
por: Toshiyuki Waki, et al.
Publicado: (2020) -
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South America.
por: Ross J Davidson, et al.
Publicado: (2008) -
Quinolone Resistance Reversion by Targeting the SOS Response
por: E. Recacha, et al.
Publicado: (2017)